VR Logo

Vanda Pharmaceuticals Inc. (VNDA) download report


Healthcare | Biotechnology & Pharma Research

Vanda Pharmaceuticals Inc. (VNDA) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs.

IPO Date: 12-Apr-2006

Founder, Pres, CEO & Chairman of The Board: Dr. Mihael H. Polymeropoulos M.D.

Sr. VP, CFO & Treasurer: Mr. Kevin Patrick Moran

Listing: NASDAQ: VNDA

Country: United States

Headquarters: Washington, DC

Website: https://www.vandapharma.com

Key Facts

Market cap: $604.44 Mln

Revenue (TTM): $266.21 Mln

Earnings (TTM): $18.07 Mln

Cash: $435.18 Mln

Total Debt: $11.96 Mln

Insider's Holding: 3.56%

Liquidity: Low

52 Week range: $9.24 - 21.86

Shares outstanding: 56,489,700

10 Years Aggregate:

  • CFO: $28.22 Mln
  • EBITDA: $-9.10 Mln
  • Net Profit: $96.08 Mln

Stock Performance

Time Period Vanda Pharmaceuticals (VNDA) S&P BSE Sensex S&P Small-Cap 600
YTD-31.42-8.74-17.05
1 month9.91-2.01-4.75
3 months-6.11-7.32-12.65
1 Year-48.220.45-16.28
3 Years-8.1410.328.01
5 Years-7.4511.296.35
10 Years9.4312.1410.55
As on 27-Jun-2022
Year Vanda Pharmaceuticals (VNDA) S&P Small-Cap 600 S&P BSE Sensex
202119.4125.2721.99
2020-19.939.5715.75
2019-37.2020.8614.38
201871.40-9.705.87
2017-4.7011.7327.91
201671.3224.741.95
2015-34.99-3.36-5.03